BOSTON, July 20, 2022 /PRNewswire/ -- Greene LLP announces that the international pharmaceutical company, Biogen, Inc, has agreed to pay $900 million to resolve claims brought by Michael Bawduniak, a client of Greene LLP, that Biogen unlawfully paid kickbacks to physicians and other healthcare professionals. The settlement will be paid to the United States and the Medicaid programs of various states in resolution of the False Claims Act action in which the United States did not intervene.
"We believe this settlement represents the largest recovery in the over 150 years of False Claims Act cases to be secured by a whistleblower without the intervention or participation of the United States," said attorney Thomas M. Greene, who served as Mr. Bawduniak's lead counsel throughout more than a decade of litigation.
In 2012, Mr. Bawduniak disclosed to the United States that he believed Biogen, for whom he was then employed, was improperly paying kickbacks to its largest prescribers to discourage them from prescribing Biogen's competitors' products. Mr. Bawduniak had reported his concerns to Biogen's compliance department, which had not taken any action. Based on Mr. Bawduniak's information, the Department of Justice and the Federal Bureau of Investigation asked Mr. Bawduniak to record conversations with Biogen employees that would substantiate his...
ST. GEORGE, Utah (ABC4) — A Utah podiatrist and two nurses have been federally indicted on fraud charges after they allegedly submitted fraudulent claims to Medicare for skin substitute services, ...